These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Structure-affinity relationships of indole-based melatonin analogs. Spadoni G; Mor M; Tarzia G Biol Signals Recept; 1999; 8(1-2):15-23. PubMed ID: 10085458 [TBL] [Abstract][Full Text] [Related]
7. Indole melatonin agonists and antagonists derived by shifting the melatonin side chain from the C-3 to the N-1 or to the C-2 indole position. Tarzia G; Diamantini G; Spadoni G Biol Signals Recept; 1999; 8(1-2):24-31. PubMed ID: 10085459 [TBL] [Abstract][Full Text] [Related]
8. Molecular pharmacology and function of melatonin receptor subtypes. Dubocovich ML; Masana MI; Benloucif S Adv Exp Med Biol; 1999; 460():181-90. PubMed ID: 10810513 [No Abstract] [Full Text] [Related]
9. How does the melatonin receptor decode a photoperiodic signal in the pars tuberalis? Morgan PJ; Messager S; Webster C; Barrett P; Ross A Adv Exp Med Biol; 1999; 460():165-74. PubMed ID: 10810511 [No Abstract] [Full Text] [Related]
10. Molecular pharmacology, regulation and function of mammalian melatonin receptors. Dubocovich ML; Rivera-Bermudez MA; Gerdin MJ; Masana MI Front Biosci; 2003 Sep; 8():d1093-108. PubMed ID: 12957828 [TBL] [Abstract][Full Text] [Related]
11. Design and synthesis of melatonin receptors agonists and antagonists. Tarzia G; Diamantini G; Mor M; Spadoni G Farmaco; 2000 Mar; 55(3):184-7. PubMed ID: 10919077 [TBL] [Abstract][Full Text] [Related]
13. The roles of valine 208 and histidine 211 in ligand binding and receptor function of the ovine Mel1a beta melatonin receptor. Conway S; Canning SJ; Barrett P; Guardiola-Lemaitre B; Delagrange P; Morgan PJ Biochem Biophys Res Commun; 1997 Oct; 239(2):418-23. PubMed ID: 9344844 [TBL] [Abstract][Full Text] [Related]
14. Melatonin receptor ligands: synthesis of new melatonin derivatives and comprehensive comparative molecular field analysis (CoMFA) study. Mor M; Rivara S; Silva C; Bordi F; Plazzi PV; Spadoni G; Diamantini G; Balsamini C; Tarzia G; Fraschini F; Lucini V; Nonno R; Stankov BM J Med Chem; 1998 Sep; 41(20):3831-44. PubMed ID: 9748358 [TBL] [Abstract][Full Text] [Related]
15. A rhodopsin-based model for melatonin recognition at its G protein-coupled receptor. Navajas C; Kokkola T; Poso A; Honka N; Gynther J; Laitinen JT Eur J Pharmacol; 1996 May; 304(1-3):173-83. PubMed ID: 8813600 [TBL] [Abstract][Full Text] [Related]
16. Melatonin: receptor-mediated events that may affect breast and other steroid hormone-dependent cancers. Baldwin WS; Barrett JC Mol Carcinog; 1998 Mar; 21(3):149-55. PubMed ID: 9537645 [TBL] [Abstract][Full Text] [Related]
18. [Research progress in the oncostatic mechanism of melatonin]. Gao L; Xu RK Sheng Li Ke Xue Jin Zhan; 2001 Apr; 32(2):160-2. PubMed ID: 12545891 [No Abstract] [Full Text] [Related]
20. Comparison of the structure-activity relationships of melatonin receptor agonists and antagonists: lengthening the N-acyl side-chain has differing effects on potency on Xenopus melanophores. Teh MT; Sugden D Naunyn Schmiedebergs Arch Pharmacol; 1998 Nov; 358(5):522-8. PubMed ID: 9840420 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]